Transform Cardiac Care for Millions of Heart Failure & At-Risk Patients
Get to the Heart of Hemodynamics
VenoVision will help medical professionals spot deterioration and guide stabilization by setting a new frontier in affordable, objective, non-invasive hemodynamic monitoring across the continuum of care.
VenoVision non-invasively provides key patient data previously limited to implants or catheterization readings.
Drive Down Costs
With VenoVision, we can drive down the billions of dollars spent on over-intensive & too late care, as well as (re)hospitalizations.
Improve
Patient Outcomes
Optimize Patient Management
& DRG Payments
Reduce the Burden
on Staff and Services
VenoVision Offers a Game-Changing Solution
Thermal Imaging-Based Biosensing Device
& Monitoring Platform
VenoVision helps medical teams understand an important, but complex question,
"Is the patient in balance?"
VenoVision will uniquely support medical teams to improve therapeutic management and outcomes of obese cardiovascular patients suffering from, or at risk of, heart failure and hemodynamic complications.
VenoVision enables medical professionals to optimize decisions
at costly junctures, such as discharge from the ICU or hospital.
Achievements
M2D2 Impact 2023
"Most Innovative Award"
2021 Israel &
2023 HealthTech Sprint
Matter Incubator
2023 Member
2022 Accelerator
Portfolio Company
Proof-of-Concept
Clinical Trial Presented at
The ICI Meeting
Canada-Israel Cardiovascular Innovation Forum 2022 Finalist
Boston Scientific Connected Patient Challenge VII
2023 Finalist